Advertisement
The Medicine Maker / Issues / 2026 / June / This Week's CGT News: World's First Solid Tumor CAR T Approved in China
Cell & Gene Industry News Research News

This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

06/30/2026 5 min read News

Share

Advertisement

Recommended

Advertisement

Related Content

BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
Industry News Research News Development & Clinical
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial

November 3, 2026

2 min read

The company also reported early efficacy and safety data from the Phase I Breakfree-2 study

Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
Industry News Research News Development & Clinical
Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis

November 2, 2026

2 min read

Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited

Amgen Expands Veeva Partnership
Biopharma Industry News Business & Trends
Amgen Expands Veeva Partnership

October 27, 2026

2 min read

Global deployment of Veeva Vault CRM aims to help Amgen uncover treatment barriers and accelerate the delivery of new therapies

Can Clinical Trials Collect Less Data Without Compromising Safety?
Industry News Development & Clinical Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?

October 22, 2026

5 min read

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

Advertisement